● Recruiting

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Condition: Alcohol Liver Disease · Sponsor: Altimmune, Inc.

PhasePhase 2

Planned participants100

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly

This description comes directly from the study's public registry record.

Talk to the study team

Yadira Ulrey, MD · 619-869-1842 · information@altimmune.com

Always discuss trial participation with your own doctor first.

Locations (43)

Altimmune Clinical Study Site	Peoria, Arizona, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Tucson, Arizona, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Tuscon, Arizona, United States	Not Yet Recruiting
Altimmune Clinical Study Site	North Little Rock, Arkansas, United States	Recruiting
Altimmune Clinical Study Site	Fresno, California, United States	Not Yet Recruiting
Altimmune Clinical Study Site	La Jolla, California, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Pasadena, California, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Englewood, Colorado, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Bradenton, Florida, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Doral, Florida, United States	Not Yet Recruiting
Altimmune Clinical Study Site	Doral, Florida, United States	Recruiting
Altimmune Clinical Study Site	Fort Myers, Florida, United States	Not Yet Recruiting

+ 31 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07009860